Dashboard
Manage Tickers

SEER Seer, Inc.

Nasdaq seer.bio


$ 2.07 $ -0.07 (-3.24 %)    

Friday, 07-Nov-2025 15:57:27 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.09
$ 2.14
$ 2.04 x 1,000
$ 2.26 x 357
$ 2.05 - $ 2.14
$ 1.62 - $ 2.63
252,764
na
116.6M
$ 2.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-03-2025 01-01-1970 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-04-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-06-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-29-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

seer-unveils-multi-disease-proteomics-insights-using-proteograph-platform-during-hupo-2025-world-congress
Seer Unveils Multi-Disease Proteomics Insi...
11/07/2025 12:10:32

seer-affirms-fy2025-sales-guidance-of-17000m-18000m-vs-17500m-est
Seer Affirms FY2025 Sales Guidance of $17....
11/06/2025 21:16:02

Seer (NASDAQ:SEER) affirms FY2025 sales outlook from $17.000 million-$18.000 million to $17.000 million-$18.000 million vs $17....

seer-q3-eps-032-misses-031-estimate-sales-4121m-beat-4000m-estimate
Seer Q3 EPS $(0.32) Misses $(0.31) Estimat...
11/06/2025 21:15:06

Seer (NASDAQ:SEER) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.2...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Core News & Articles
RetinalGenix And Seer Bio Collaborate To U...
10/16/2025 09:43:32

seer-demonstrates-how-proteograph-platform-advances-disease-research-at-american-society-of-human-genetics-meeting
Seer Demonstrates How Proteograph Platform...
10/10/2025 11:04:06

Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participat...

seer-affirms-fy2025-sales-guidance-of-17000m-18000m-vs-17650m-est
Seer Affirms FY2025 Sales Guidance of $17....
08/06/2025 20:10:44

Seer (NASDAQ:SEER) affirms FY2025 sales outlook from $17.000 million-$18.000 million to $17.000 million-$18.000 million vs $17....

seer-q2-eps-033-beats-037-estimate-sales-410m-beat-375m-estimate
Seer Q2 EPS $(0.33) Beats $(0.37) Estimate...
08/06/2025 20:10:11

Seer (NASDAQ:SEER) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.37) by 10.81...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

reported-june-1-2025-seer-and-korea-university-launch-large-scale-study-using-proteograph-one-assay-and-mass-spectrometry-to-identify-early-onset-cancer-biomarkers-in-young-adults
Reported June 1, 2025: Seer And Korea Univ...
06/02/2025 15:15:34

First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, ...

seer-affirms-fy2025-sales-guidance-of-1700m-1800m-vs-1716m-est
Seer Affirms FY2025 Sales Guidance of $17....
05/13/2025 20:22:06

seer-q1-eps-034-beats-037-estimate-sales-421m-beat-325m-estimate
Seer Q1 EPS $(0.34) Beats $(0.37) Estimate...
05/13/2025 20:15:24

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

seer-sees-fy2025-sales-17000m-18000m-vs-1903m-est
Seer Sees FY2025 Sales $17.000M-$18.000M v...
02/27/2025 21:37:55

Seer (NASDAQ:SEER) sees FY2025 sales of $17.000 million-$18.000 million vs $19.03 million analyst estimate.

seer-q4-eps-037-misses-035-estimate-sales-400m-beat-395m-estimate
Seer Q4 EPS $(0.37) Misses $(0.35) Estimat...
02/27/2025 21:37:20

Seer (NASDAQ:SEER) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.35) by 5.7...

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

seer-q3-2024-gaap-eps-035-misses-029-estimate-sales-4032m-beat-3150m-estimate
Seer Q3 2024 GAAP EPS $(0.35) Misses $(0.2...
11/06/2024 21:57:25

Seer (NASDAQ:SEER) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.29) by 20....

seer-affirms-fy2024-sales-guidance-from-1300m-1500m-to-1300m-1500m
Seer Affirms FY2024 Sales Guidance from $1...
11/06/2024 21:31:48

Seer (NASDAQ:SEER) affirms FY2024 sales outlook from $13.00 million-15.00 million to $13.00 million-15.00 million.

seer-inc-announced-a-co-marketing-and-sales-agreement-with-thermo-fischer-scientific-terms-not-disclosed
Seer Inc Announced A Co-Marketing And Sale...
11/06/2024 21:05:07

morgan-stanley-maintains-equal-weight-on-seer-lowers-price-target-to-3
Morgan Stanley Maintains Equal-Weight on S...
08/13/2024 12:51:15

Morgan Stanley analyst Yuko Oku maintains Seer (NASDAQ:SEER) with a Equal-Weight and lowers the price target from $7 to $3.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION